Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

Verhagen, Nathaniel B; Koerber, Nicolas K; Szabó, Anikó; Taylor, Bradley; Wainaina, J Njeri; Evans, Douglas B.; Kothari, Anai N.

doi:10.1245/s10434-022-12916-z

Cited by 6 publications

(6 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We would like to share our ideas on the publication ''Vaccination against SARS-CoV-2 Decreases Risk of Adverse Events in Patients Who Develop COVID-19 following Cancer Surgery.'' 1 Verhagen et al investigated the effect of vaccination on these outcomes and reported 30-day unfavorable postoperative event rates in individuals who develop postoperative COVID-19. 1 The risk of developing COVID-19 after surgery is not prevented by vaccination, however Verhagen et al reported that postoperative SARS-CoV-2 infection is still a substantial risk factor for mortality and morbidity.…”

Section: Dear Editormentioning

confidence: 99%

“…1 Verhagen et al investigated the effect of vaccination on these outcomes and reported 30-day unfavorable postoperative event rates in individuals who develop postoperative COVID-19. 1 The risk of developing COVID-19 after surgery is not prevented by vaccination, however Verhagen et al reported that postoperative SARS-CoV-2 infection is still a substantial risk factor for mortality and morbidity. 1 Vaccination lowers the risk of negative postoperative outcomes.…”

Section: Dear Editormentioning

confidence: 99%

“…1 The risk of developing COVID-19 after surgery is not prevented by vaccination, however Verhagen et al reported that postoperative SARS-CoV-2 infection is still a substantial risk factor for mortality and morbidity. 1 Vaccination lowers the risk of negative postoperative outcomes. Verhagen et al came to the conclusion that, although postoperative COVID-19 infection is a rare complication in patients receiving oncologic resection, it is nevertheless extremely harmful.…”

Section: Dear Editormentioning

confidence: 99%

“…A vital, generally accessible strategy to reduce this risk is the SARS-CoV-2 vaccine, which ought to be a requirement for preoperative optimization. 1 There are several considerations that need to be made in order to arrive at an accurate interpretation. One of the potential confounding variables that could have affected the outcomes of the initial dose was a real poor reaction.…”

Section: Dear Editormentioning

confidence: 99%

See 3 more Smart Citations

COVID-19 Vaccination in Patients Who Develop COVID-19 following Cancer Surgery: Correspondence

Mungmunpuntipantip¹,

Wiwanitkit

2023

Ann Surg Oncol

View full text Add to dashboard Cite

Section: Dear Editormentioning

confidence: 99%

Section: Dear Editormentioning

confidence: 99%

Section: Dear Editormentioning

confidence: 99%

Section: Dear Editormentioning

confidence: 99%

See 2 more Smart Citations

COVID-19 Vaccination in Patients Who Develop COVID-19 following Cancer Surgery: Correspondence

Mungmunpuntipantip¹,

Wiwanitkit

2023

Ann Surg Oncol

View full text Add to dashboard Cite

“… 4 Finally, our study shows that vaccination decreases the risk of developing adverse surgical outcomes in patients with postoperative COVID-19, suggesting that those included in our study did confer benefit following vaccination. 5 …”

mentioning

confidence: 99%

Reply to: COVID-19 Vaccination in Patients who Develop COVID-19 After Cancer Surgery: Correspondence by Mungmunpuntipantip and Wiwanitkit

Verhagen

Kothari

2023

Ann Surg Oncol

Self Cite

View full text Add to dashboard Cite

Risk of Early Postoperative Cardiovascular and Cerebrovascular Complication in Patients with Preoperative COVID-19 Undergoing Cancer Surgery

SenthilKumar,

Verhagen,

Nimmer

et al. 2024

Journal of the American College of Surgeons

View full text Add to dashboard Cite

Background: As the COVID-19 pandemic shifts to an endemic phase, an increasing proportion of cancer patients with a preoperative history of COVID-19 will require surgery. This study aimed to assess the influence of preoperative COVID-19 on postoperative risk for major adverse cardiovascular and cerebrovascular events (MACE) among those undergoing surgical cancer resection. Secondary objectives included determining optimal time-to-surgery guidelines based on COVID-19 severity and discerning the influence of vaccination status on MACE risk. Study Design: National COVID Cohort Collaborative (N3C) Data Enclave, a large multi-institutional dataset, was used to identify patients that underwent surgical cancer resection between January 2020 and February 2023. Multivariate regression analysis adjusting for demographics, comorbidities, and risk of surgery was performed to evaluate risk for 30-day postoperative MACE. Results: Of 204,371 included patients, 21,313 (10.4%) patients had a history of preoperative COVID-19. History of COVID-19 was associated with an increased risk for postoperative composite MACE as well as 30-day mortality. Among patients with mild disease who did not require hospitalization, MACE risk was elevated for up to 4-weeks following infection. Postoperative MACE risk remained elevated 8+ weeks following infection in those with moderate disease. Vaccination did not reduce risk for postoperative MACE. Conclusion: Together, these data highlight that assessment of the severity of preoperative COVID-19 infection should be a routine component of both preoperative patient screening as well as surgical risk stratification. In addition, strategies beyond vaccination that increase patients’ cardiovascular fitness and prevent COVID-19 infection are needed.

show abstract

Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

Cited by 6 publications

References 4 publications

COVID-19 Vaccination in Patients Who Develop COVID-19 following Cancer Surgery: Correspondence

COVID-19 Vaccination in Patients Who Develop COVID-19 following Cancer Surgery: Correspondence

Reply to: COVID-19 Vaccination in Patients who Develop COVID-19 After Cancer Surgery: Correspondence by Mungmunpuntipantip and Wiwanitkit

Risk of Early Postoperative Cardiovascular and Cerebrovascular Complication in Patients with Preoperative COVID-19 Undergoing Cancer Surgery

Contact Info

Product

Resources

About